Cox R F, Waszczak B L
Pharmacology Section, Northeastern University, College of Pharmacy, Boston, Massachusetts 02115.
Mol Pharmacol. 1989 Jan;35(1):125-31.
Previous studies with (S)-(+)-N-n-propylnorapomorphine (NPA), an enantiomer of the potent dopaminergic agonist (R)-(-)-NPA, showed that this compound had a complex pharmacological profile. For example, (S)-(+)NPA had weak dopaminergic agonist potency, in that it could slow and ultimately stop firing of substantia nigra and ventral tegmental area dopamine neurons. However, antagonist properties were also evident inasmuch as immediate pretreatment with a low dose of (S)-(+)-NPA caused a significant rightward shift of the (R)-(-)-NPA dose-response curve. This dual agonist-antagonist nature of (S)-(+)-NPA suggested a low intrinsic efficacy for (S)-(+)-NPA. To test this hypothesis, we conducted dose-response studies for the inhibition of rat substantia nigra dopamine cell firing by (R)-(-)- and (S)-(+)-NPA 1 day after partial irreversible dopamine receptor inactivation with 6 mg/kg N-ethoxycarbonyl-2-ethoxy-1-2-dihydroquinoline (EEDQ) in an ethanol vehicle. This degree of inactivation resulted in a significant, parallel, rightward shift of the (R)-(-)-NPA dose-response curve relative to ethanol-treated control rats, with no loss of maximal response. After pretreatment with the same dose of EEDQ, however, the maximal response to (S)-(+)-NPA was reduced by 22% with no shift on the dose axis. The dose-response curves for control and EEDQ-treated groups were subjected to Furchgott analysis to determine per cent response versus fractional occupancy relationships for each drug. A steep hyperbolic relationship was revealed for (R)-(-)-NPA. Fifty per cent and maximal (greater than 95%) inhibitions of cell firing occurred at 3.5% and approximately 32% receptor occupancies, respectively. Hence, for (R)-(-)-NPA there is about a 68% receptor reserve in this model. The same analysis for (S)-(+)-NPA yielded an occupancy versus response plot that was more shallow and linear. Half-maximal effects occurred at 66% occupancy and the maximal response (96% inhibition) required 94% occupancy, indicating few spare receptors for (S)-(+)-NPA. Because the ratio of fractional occupancies at a given level of response is a measure of relative efficacy, we calculated a relative efficacy of (S)-(+)- to (R)-(-)-NPA of 0.05 (at the 50% response level). This confirms that (S)-(+)-NPA indeed has a much lower intrinsic efficacy than the (R)-(-)-antipode and may account for the previously reported antagonist property of the (+)-form under certain treatment conditions.
先前对强效多巴胺能激动剂(R)-(-)-N-正丙基去甲阿扑吗啡(NPA)的对映体(S)-(+)-N-正丙基去甲阿扑吗啡的研究表明,该化合物具有复杂的药理学特性。例如,(S)-(+)-NPA具有较弱的多巴胺能激动剂效力,因为它可以减缓并最终停止黑质和腹侧被盖区多巴胺能神经元的放电。然而,拮抗剂特性也很明显,因为用低剂量的(S)-(+)-NPA进行即刻预处理会导致(R)-(-)-NPA剂量-反应曲线显著右移。(S)-(+)-NPA的这种双重激动剂-拮抗剂性质表明其内在效力较低。为了验证这一假设,我们在用6 mg/kg N-乙氧基羰基-2-乙氧基-1,2-二氢喹啉(EEDQ)在乙醇载体中进行部分不可逆多巴胺受体失活1天后,对(R)-(-)-和(S)-(+)-NPA抑制大鼠黑质多巴胺细胞放电进行了剂量-反应研究。这种失活程度导致(R)-(-)-NPA剂量-反应曲线相对于乙醇处理的对照大鼠显著、平行地右移,且最大反应无损失。然而,在用相同剂量的EEDQ预处理后,对(S)-(+)-NPA的最大反应降低了22%,剂量轴上无移位。对对照组和EEDQ处理组的剂量-反应曲线进行弗奇戈特分析,以确定每种药物的反应百分比与占据分数的关系。(R)-(-)-NPA呈现出陡峭的双曲线关系。细胞放电的50%抑制和最大(大于95%)抑制分别发生在3.5%和约32%的受体占据率时。因此,在该模型中,(R)-(-)-NPA约有68%的受体储备。对(S)-(+)-NPA的相同分析得出的占据率与反应图更浅且呈线性。半数最大效应发生在66%的占据率时,最大反应(96%抑制)需要94%的占据率,表明(S)-(+)-NPA几乎没有备用受体。由于在给定反应水平下占据分数的比值是相对效力的一种衡量,我们计算出(S)-(+)-与(R)-(-)-NPA的相对效力为0.05(在50%反应水平)。这证实了(S)-(+)-NPA确实比(R)-(-)-对映体具有低得多的内在效力,这可能解释了先前报道的在某些治疗条件下(+)-形式的拮抗剂性质。